Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2017
At a glance
- Drugs Avatrombopag (Primary)
- Indications Thrombocytopenia
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 17 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jan 2014 New trial record